A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

PrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

The increasing incidence of sexually transmitted bacterial infections (STIs) is a major public health problem worldwide.

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ... Doxycycline post-exposure prophylaxis increases tetracycline ...

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...

Human immunodeficiency virus (HIV) is a condition that attacks a person's immune system. The immune system helps identify and destroy pathogens that cause infection and illness in the body. The risk ...

A health worker takes blood samples of people who want to undertake voluntary HIV testing at the University of the Philippines Manila. Jonathan Cellona, ABS-CBN News/FileMANILA — The Philippines ...

Biktarvy is a complete treatment for HIV, which means that you don’t need to take any other drugs with it. Biktarvy is meant to be used as a long-term treatment. If you and your doctor determine ...

Ireland based pharmaceutical company Gilead Sciences has said it will grant licences to six generic manufacturers to produce low cost lenacapavir, which has shown unprecedented efficacy at preventing ...

How Was It Studied for the Prevention of HIV? Two large studies were conducted ... for approximately one month to determine if you can tolerate the medication. After two initial injections one ...